Cabaletta Bio Stock Performance
| CABA Stock | USD 2.51 0.18 7.73% |
Cabaletta Bio has a performance score of 2 on a scale of 0 to 100. The firm shows a Beta (market volatility) of 1.13, which signifies a somewhat significant risk relative to the market. Cabaletta Bio returns are very sensitive to returns on the market. As the market goes up or down, Cabaletta Bio is expected to follow. Cabaletta Bio right now shows a risk of 5.54%. Please confirm Cabaletta Bio total risk alpha, potential upside, and the relationship between the standard deviation and maximum drawdown , to decide if Cabaletta Bio will be following its price patterns.
Risk-Adjusted Performance
Weak
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Cabaletta Bio are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unfluctuating fundamental drivers, Cabaletta Bio may actually be approaching a critical reversion point that can send shares even higher in March 2026. ...more
Actual Historical Performance (%)
One Day Return 7.73 | Five Day Return (0.40) | Year To Date Return 13.57 | Ten Year Return (74.90) | All Time Return (74.90) |
1 | Will Cabaletta Bio Inc. stock outperform Nasdaq index - Earnings Recap Summary Expert Verified Stock Movement Alerts - newser.com | 11/19/2025 |
2 | Chipmakers Recap Will Cabaletta Bio Inc stock split again soon - Market Trend Report Weekly High Potential Stock Alerts - moha.gov.vn | 12/23/2025 |
3 | Cabaletta Bio Announces 2026 Strategic Priorities | 01/12/2026 |
4 | Acquisition by Gerard Michael of 6600 shares of Cabaletta Bio at 2.2696 subject to Rule 16b-3 | 01/21/2026 |
5 | Cabaletta Bio Insider David Chang Purchases 8,800 Shares | 01/22/2026 |
6 | Is Cabaletta Bio Outperforming Other Medical Stocks This Year | 01/27/2026 |
7 | Disposition of 100000 shares by Das Arun of Cabaletta Bio at 23.97 subject to Rule 16b-3 | 02/03/2026 |
8 | Acquisition by Chang David J. of 135000 shares of Cabaletta Bio at 1.92 subject to Rule 16b-3 | 02/04/2026 |
9 | Cabaletta Bio to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 | 02/05/2026 |
| Begin Period Cash Flow | 193.2 M | |
| Total Cashflows From Investing Activities | 47.3 M |
Cabaletta | Build AI portfolio with Cabaletta Stock |
Cabaletta Bio Relative Risk vs. Return Landscape
If you would invest 247.00 in Cabaletta Bio on November 11, 2025 and sell it today you would earn a total of 4.00 from holding Cabaletta Bio or generate 1.62% return on investment over 90 days. Cabaletta Bio is currently generating 0.1692% in daily expected returns and assumes 5.5395% risk (volatility on return distribution) over the 90 days horizon. In different words, 49% of stocks are less volatile than Cabaletta, and 97% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Cabaletta Bio Target Price Odds to finish over Current Price
The tendency of Cabaletta Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 2.51 | 90 days | 2.51 | about 34.46 |
Based on a normal probability distribution, the odds of Cabaletta Bio to move above the current price in 90 days from now is about 34.46 (This Cabaletta Bio probability density function shows the probability of Cabaletta Stock to fall within a particular range of prices over 90 days) .
Cabaletta Bio Price Density |
| Price |
Predictive Modules for Cabaletta Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cabaletta Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cabaletta Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cabaletta Bio is not an exception. The market had few large corrections towards the Cabaletta Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cabaletta Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cabaletta Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.23 | |
β | Beta against Dow Jones | 1.13 | |
σ | Overall volatility | 0.25 | |
Ir | Information ratio | -0.04 |
Cabaletta Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cabaletta Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cabaletta Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cabaletta Bio had very high historical volatility over the last 90 days | |
| Net Loss for the year was (115.86 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cabaletta Bio currently holds about 96.81 M in cash with (88.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cabaletta Bio has a frail financial position based on the latest SEC disclosures | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Cabaletta Bio to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 |
Cabaletta Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Cabaletta Stock often depends not only on the future outlook of the current and potential Cabaletta Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Cabaletta Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 49.5 M | |
| Cash And Short Term Investments | 164 M |
Cabaletta Bio Fundamentals Growth
Cabaletta Stock prices reflect investors' perceptions of the future prospects and financial health of Cabaletta Bio, and Cabaletta Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cabaletta Stock performance.
| Return On Equity | -1.01 | ||||
| Return On Asset | -0.52 | ||||
| Current Valuation | 106.99 M | ||||
| Shares Outstanding | 96.27 M | ||||
| Price To Earning | (3.33) X | ||||
| Price To Book | 1.73 X | ||||
| EBITDA | (110.3 M) | ||||
| Net Income | (115.86 M) | ||||
| Cash And Equivalents | 96.81 M | ||||
| Cash Per Share | 3.34 X | ||||
| Total Debt | 15.6 M | ||||
| Debt To Equity | (3.76) % | ||||
| Current Ratio | 15.22 X | ||||
| Book Value Per Share | 1.45 X | ||||
| Cash Flow From Operations | (88.22 M) | ||||
| Earnings Per Share | (2.40) X | ||||
| Market Capitalization | 241.63 M | ||||
| Total Asset | 185.05 M | ||||
| Retained Earnings | (349.1 M) | ||||
| Working Capital | 139.59 M | ||||
| Current Asset | 30.42 M | ||||
| Current Liabilities | 843.74 K | ||||
About Cabaletta Bio Performance
By analyzing Cabaletta Bio's fundamental ratios, stakeholders can gain valuable insights into Cabaletta Bio's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cabaletta Bio has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cabaletta Bio has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.72) | (0.76) | |
| Return On Capital Employed | (0.91) | (0.87) | |
| Return On Assets | (0.72) | (0.76) | |
| Return On Equity | (0.87) | (0.83) |
Things to note about Cabaletta Bio performance evaluation
Checking the ongoing alerts about Cabaletta Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cabaletta Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cabaletta Bio had very high historical volatility over the last 90 days | |
| Net Loss for the year was (115.86 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Cabaletta Bio currently holds about 96.81 M in cash with (88.22 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.34, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Cabaletta Bio has a frail financial position based on the latest SEC disclosures | |
| Over 78.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from finance.yahoo.com: Cabaletta Bio to Participate in the Guggenheim Emerging Outlook Biotech Summit 2026 |
- Analyzing Cabaletta Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cabaletta Bio's stock is overvalued or undervalued compared to its peers.
- Examining Cabaletta Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cabaletta Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cabaletta Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cabaletta Bio's stock. These opinions can provide insight into Cabaletta Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cabaletta Stock analysis
When running Cabaletta Bio's price analysis, check to measure Cabaletta Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cabaletta Bio is operating at the current time. Most of Cabaletta Bio's value examination focuses on studying past and present price action to predict the probability of Cabaletta Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cabaletta Bio's price. Additionally, you may evaluate how the addition of Cabaletta Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |